Trial record 1 of 3 for:
RMC-6236
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT05379985 |
|
Recruitment Status :
Recruiting
First Posted : May 18, 2022
Last Update Posted : February 23, 2024
|
Sponsor:
Revolution Medicines, Inc.
Information provided by (Responsible Party):
Revolution Medicines, Inc.
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Estimated Primary Completion Date : | June 2024 |
| Estimated Study Completion Date : | December 2025 |